Roche has announced that the primary endpoint has been met for the phase III HAVEN 1 study evaluating emicizumab prophylaxis in people 12 years of age or older with haemophilia A and inhibitors to factor VIII. The study showed a statistically-significant reduction in the number of bleeds over time in people treated with emicizumab prophylaxis [...]
The US Food and Drug Administration has approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement. Spinraza is an injection administered into the fluid surrounding the spinal cord. ‘There has been a long-standing need for [...]
The national provider company, Healthcare Together, that has been formed with NPA and PSNC members, and the support of CCA and AIMp, has launched a tender scanning service. LPCs will now automatically receive notification of relevant tenders in their region and LPC supported local provider companies can register to receive the alerts. The details of [...]
A new, computer-based screening method could reveal the virus-fighting potential of drugs originally developed to treat other conditions, reports a study in PLOS Computational Biology. Every year, viral infections cause millions of deaths worldwide. While traditional drug development can yield powerful new antiviral medications, repurposing existing drugs that are already well understood is an appealing [...]
Since 2013 the FDA has allowed eight plants whose products are otherwise banned from the US to go ahead and import some drugs or ingredients to avoid shortages, according to FDA Import Alert records. Reported on www.wessexlifescience.co.uk, because of the nature of the business, with companies in China or India often being a primary source of [...]
Well, the UK’s largest independent pharmacy chain, is introducing a radical new retail concept – The Pharmacy Shop. Following extensive customer research and feedback, the brand will challenge current perceptions of Well’s existing offering and those of the wider industry, by offering a customer-led, modern, retail destination to meet today’s customers’ health and wellbeing needs. [...]
Hospital pharmacists can now call on a unique new web-based tool, PharmacyView, to help them provide a more responsive, effective and precise service to patients. PharmacyView has been developed by Nugensis with a particular interest in health and social care, in partnership with NHS hospital pharmacists. It’s already in use across five NHS Boards in [...]
Mylan NV has announced the US launch of Metoprolol Tartrate Tablets USP, 37.5mg and 75mg, which is the generic version of Novartis' Lopressor® Tablets. These strengths are the first and only available intermediate dosage strengths between the existing Metoprolol Tartrate Tablets USP strengths of 25mg, 50mg and 100mg. Mylan currently is the only manufacturer that [...]
A new report from business intelligence provider GBI Research – Frontier Pharma: Schizophrenia and Associated Indications – states that although the schizophrenia market is replete with unmet needs and its pipeline is paltry, the overall level of innovation for schizophrenia-related indications – which comprise depression, panic disorders, obsessive compulsive disorder, post-traumatic stress disorder and cognitive [...]
Martindale Pharma, the UK-based international specialty pharmaceutical company, has announced the UK launch of Phenylephrine, a new strength of the selective vasopressor drug for the treatment of hypotension associated with anaesthesia. Phenylephrine will be available in a 10ml ampoule at a strength of 0.1mg/ml. This new strength not only allows for accurate dose dispensing but also [...]
